nivolumab,brentuximab,doxorubicin hydrochloride,dacarbazine,filgrastim,pegfilgrastim,vinblastine sulfate
seagen,bms,amgen
['thanks']
disease-free survival also better with n-avd than bv-avd good to see details of types of events given promising early overall survival curves (thanks for speedy photo ) with more deaths in bv-avd arm
#asco23 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem